Barely Significant
← all excerpts

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

PLoS One · 2012 · PMC3384658 · PMID 22761653

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.